Bank Of New York Mellon Corp Soligenix, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.4 - $168.0 $10,327 - $4.34 Million	25,818 New	25,818 $11,000
Q3 2022 Nov 14, 2022	BUY	$0.51 - $117.79 $0 - $117	1 Added 0.0%	25,818 $11,000
Q3 2021 Nov 12, 2021	SELL	$0.9 - $1.31 $1,800 - $2,620	-2,000 Reduced 7.19%	25,817 $27,000
Q2 2021 Aug 11, 2021	BUY	$0.87 - $1.58 $1,740 - $3,160	2,000 Added 7.75%	27,817 $30,000
Q1 2021 May 13, 2021	SELL	$1.31 - $2.35 $3,474 - $6,232	-2,652 Reduced 9.32%	25,817 $39,000
Q4 2020 Feb 09, 2021	BUY	$1.26 - $2.75 $35,870 - $78,289	28,469 New	28,469 $36,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.